The Cooper Companies, Inc. (NASDAQ:COO) Stock Holdings Lifted by Select Equity Group L.P.

Select Equity Group L.P. lifted its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 56.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 262,809 shares of the medical device company's stock after purchasing an additional 94,466 shares during the quarter. Select Equity Group L.P. owned 0.13% of Cooper Companies worth $24,160,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. Price T Rowe Associates Inc. MD raised its holdings in Cooper Companies by 517.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock valued at $324,466,000 after buying an additional 2,957,421 shares during the period. Norges Bank acquired a new stake in shares of Cooper Companies during the fourth quarter worth about $217,906,000. FMR LLC raised its position in Cooper Companies by 97.6% during the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock valued at $203,911,000 after acquiring an additional 1,095,805 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Cooper Companies in the fourth quarter valued at approximately $64,826,000. Finally, Victory Capital Management Inc. boosted its stake in shares of Cooper Companies by 14.6% in the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after acquiring an additional 574,899 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Piper Sandler restated an "overweight" rating and issued a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Citigroup cut their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Finally, Robert W. Baird cut their price objective on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, Cooper Companies has a consensus rating of "Moderate Buy" and a consensus target price of $110.25.

Cooper Companies Price Performance

NASDAQ:COO traded down $0.41 during midday trading on Tuesday, hitting $81.50. 2,115,822 shares of the stock were exchanged, compared to its average volume of 1,478,313. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38. The company has a market capitalization of $16.30 billion, a price-to-earnings ratio of 41.80, a P/E/G ratio of 2.25 and a beta of 1.08. The business has a 50-day moving average price of $80.25 and a two-hundred day moving average price of $89.83. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million for the quarter, compared to analysts' expectations of $981.25 million. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.